Table 1.
Characteristics of people with CSD vs without CSD in terms of sex, age, residential status, deprivation, comorbidities, and functional status
No CSDs | Any CSDs | |
---|---|---|
| ||
All patients (N=6,724) | (N=4,344) | (N=2,380) |
Sex | ||
Female (N=3,784) | 2,375 (54.6) | 1,409 (59.2) |
Age (years), mean (SD) | 77.6 (7.7) | 82.1 (7.7) |
65–69 (N=955) | 788 (18.1) | 167 (7) |
70–74 (N=1,123) | 867 (20.0) | 256 (10.8) |
75–79 (N=1,322) | 902 (20.8) | 421 (17.7) |
80–84 (N=1,420) | 871 (20.1) | 549 (23.1) |
85+ (N=1,904) | 916 (21.1) | 988 (41.5) |
Residential status | ||
Care home (N=500) | 75 (1.7) | 425 (17.9) |
SIMDa | ||
1, most deprived (N=1,376) | 919 (21.2) | 456 (19.2) |
2 (N=1,789) | 1,136 (26.1) | 653 (27.4) |
3 (N=1,548) | 983 (22.6) | 565 (23.7) |
4 (N=1,032) | 654 (15.1) | 378 (15.9) |
5, least deprived (N=979) | 652 (15) | 327 (13.7) |
CCI groupsb | ||
CCI 0 (N=1,629) | 992 (22.8) | 647 (27.2) |
CCI 1 (N=1,728) | 1,152 (26.5) | 576 (24.2) |
CCI 2–5 (N=2,733) | 1,756 (40.4) | 977 (41.1) |
CCI 6+ (N=624) | 449 (10.2) | 180 (7.6) |
No. of drugsc | ||
0 (N=389) | 227 (5.2) | 162 (6.8) |
1–5 (N=1,725) | 1,108 (25.5) | 617 (25.9) |
6–10 (N=2,650) | 1,726 (39.7) | 924 (38.8) |
10+ (N=1,960) | 1,283 (29.5) | 677 (28.5) |
ADL groups (N=4,846)a | (n=2,871) | (n=1,975) |
Persistently low ADL (N=1,144) | 314 (10.9) | 830 (42.0) |
Changed ADL (N=1,656) | 886 (30.9) | 770 (39.0) |
Persistently high ADL (N=2,046) | 1,671 (58.2) | 375 (19.0) |
Notes: All data are represented as n (%) except where indicated.
Scottish Index of Multiple Deprivation divided into five quintiles.
Charlson Comorbidity Index groups based on ICD10 codes in SMR01 data set.
Number of drugs prescribed during the 84 days prior to admission.
ADL based on current and 3 months prior to admission, 27% of which are missing.
Abbreviations: CSD, cognitive spectrum disorder; ADL, activity of daily living; CCI, Charlson Comorbidity Index; SIMD, Scottish Index of Multiple Deprivation.